Jinyu Bio-Technology Co

Jinyu Bio-Technology Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 87.95. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 79.86 — a change of 10.13% (higher).

EV/FCF

87.95

YoY

10.13%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Jinyu Bio-Technology Co is 2025 87.95 . EV/FCF (Enterprise Value to Free Cash Flow) of Jinyu Bio-Technology Co was 2024 79.86 . It decreases by 10.13% higher compared to the previous year.

The Jinyu Bio-Technology Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-125.18 CNY
Jan 1, 2019
157.15 CNY
Jan 1, 2020
31.97 CNY
Jan 1, 2021
97.30 CNY
Jan 1, 2022
101.47 CNY
Jan 1, 2023
108.54 CNY
Jan 1, 2024
79.86 CNY
Jan 1, 2025
87.95 CNY
The Jinyu Bio-Technology Co EV/FCF history
YEAREV/FCFYoY
87.95+10.13%
79.86-26.42%
108.54+6.96%
101.47+4.29%
97.30+204.36%
31.97-79.66%
157.15-225.54%
-125.18-517.55%
29.98+26.62%
23.68-65.87%
69.36+62.33%
42.73—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Jinyu Bio-Technology Co is 87.95 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Jinyu Bio-Technology Co changed from 79.86 to 87.95, representing a 10.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Jinyu Bio-Technology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Jinyu Bio-Technology Co